Alphatec Holdings (ATEC) Total Non-Current Liabilities (2010 - 2026)

Alphatec Holdings (ATEC) reported Total Non-Current Liabilities of $789.4 million for Q1 2026, up 16.29% on a YoY basis from $678.8 million in Q1 2025, and up 1.14% sequentially from $780.5 million in Q4 2025.

Alphatec Holdings (ATEC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Alphatec Holdings (ATEC) has 17 years of Total Non-Current Liabilities data on file, last reported at $789.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 16.29% year-over-year to $789.4 million; the trailing twelve-month figure through Mar 2026 stood at $789.4 million (up 16.29% YoY), and the FY2025 full-year result was $780.5 million, up 2.12% from the prior year.
  • Total Non-Current Liabilities advanced to $789.4 million in Q1 2026, from $780.5 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $794.0 million in Q4 2023 to a low of $496.2 million in Q2 2022.
  • A 5-year average of $675.7 million and a median of $733.5 million in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities retreated 13.69% in 2022 and jumped 54.34% in 2023, its largest moves.
  • Tracing ATEC's Total Non-Current Liabilities over 5 years: stood at $514.4 million in 2022, then jumped by 54.34% to $794.0 million in 2023, then retreated by 3.74% to $764.3 million in 2024, then gained by 2.12% to $780.5 million in 2025, then gained by 1.14% to $789.4 million in 2026.
  • Business Quant data shows ATEC's Total Non-Current Liabilities at $789.4 million in Q1 2026, $780.5 million in Q4 2025, and $776.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Alphatec Holdings 1.26 Bn 1.12 Bn 136.48 Mn 789.39 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 789.39 Mn
Dec 31, 2025 780.47 Mn
Sep 30, 2025 775.98 Mn
Jun 30, 2025 779.75 Mn
Mar 31, 2025 678.81 Mn
Dec 31, 2024 764.29 Mn
Sep 30, 2024 733.54 Mn
Jun 30, 2024 756.67 Mn
Mar 31, 2024 763.40 Mn
Dec 31, 2023 794.01 Mn
Sep 30, 2023 658.60 Mn
Jun 30, 2023 614.83 Mn
Mar 31, 2023 553.51 Mn
Dec 31, 2022 514.44 Mn
Sep 30, 2022 501.80 Mn
Jun 30, 2022 496.19 Mn
Mar 31, 2022 532.06 Mn
Dec 31, 2021 570.53 Mn
Sep 30, 2021 581.36 Mn
Jun 30, 2021 437.68 Mn